Nath Bio-Genes (India) Limited
Incorporated in 1993, Nath Bio-Genes Ltdis in the business of Production, Processing,and Marketing of Hybrid and GM Seeds
What Nath files
- Others30
- Important11
- Board Meeting7
- Updates6
- Investor Meet3
- Dividend/Bonus2
Nath Bio-Genes has set Friday, September 11, 2026, as the cut-off date. This date determines which shareholders are eligible to vote at the company's 33rd Annual General Meeting. The AGM is scheduled for Thursday, September 24, 2026, and will be held via Video Conferencing/Other Audio Visual Means.
Nath Bio-Genes (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
Nath Bio-Genes (India) Limited has informed the Exchange about Initiation of Forensic Audit
Nath Bio-Genes delivered strong Q1FY27 results: Revenue grew 15% to ₹322.8 Cr, EBITDA rose 17% to ₹35.1 Cr, and PAT increased 12% to ₹32.7 Cr. Operational highlights include Maize volume up 44% (value 59%) and Paddy volume up 19% (value 34%).
Nath Bio-Genes board met and approved Q1 consolidated results. Net Profit surged to Rs 32.26 Cr from a loss last quarter, with revenue at Rs 328.40 Cr. The 33rd Annual General Meeting is scheduled for September 24, 2026.